Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
32.80
Dollar change
+0.29
Percentage change
0.88
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y10.09% Shs Outstand Perf Week0.42%
SponsorFranklin Templeton ETF Type Tagsequity Return% 3Y-7.43% Total Holdings69 Perf Month0.06%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM9.76M Perf Quarter7.19%
Index- Average Maturity Tagsgenomics Return% 10Y NAV% Perf Half Y16.43%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year10.04%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range25.26 - 32.92 Perf YTD7.65%
Dividend TTM- ESG Type Tags- Flows% 3M-13.33% 52W High-0.37% Beta1.05
Dividend Ex-DateDec 30, 2021 Dividend Type Sector/Theme Flows% YTD-13.33% 52W Low29.85% ATR (14)0.28
Expense0.50% Structure Type Region Flows% 1Y RSI (14)60.46 Volatility0.22% 0.47%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.97 Prev Close32.51
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.99K Price32.80
SMA200.80% SMA504.53% SMA20010.32% Trades Volume964 Change0.88%
Jul-16-21 11:19AM
Jan-14-21 09:15AM
Oct-05-20 08:00AM
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.